Drug details

Vijoice (alpelisib tablets)

type of Antineoplastics PI3K Inhibitors

Vijoice (alpelisib) is a kinase inhibitor indicated for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.

This drug may have the following side effects:

• shortness of breath,
• chest pain,
• cough,
• increased thirst,
• pale skin,
• dry mouth,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• confusion, 
• increased urination, 
• unusual tiredness, 
• trouble swallowing,
• fruity breath odor, 
• little or no urination, 
• cold hands and feet, 
• red or swollen gums,
• blisters or ulcers in your mouth, 
• weight loss
• severe or ongoing diarrhea, 
• hunger, and 

The following drugs are related to Vijoice, either as a replacement or used together:

• Piqray (alpelisib tablets)